Logo for Roivant Sciences Ltd

Roivant Sciences Investor Relations Material

Latest events

Logo for Roivant Sciences Ltd

Q2 2025

Roivant Sciences
Logo for Roivant Sciences

Q2 2025

12 Nov, 2024
Logo for Roivant Sciences

Study Update

10 Sep, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies

Latest reports from Roivant Sciences Ltd

Access all reports
Roivant Sciences Ltd. is a commercial-stage biopharmaceutical company established in 2014, dedicated to the development and commercialization of innovative medicines and technologies, particularly in the areas of inflammation and immunology. The company adopts a unique model, creating nimble and focused subsidiaries known as "Vants" for the development and commercialization of its medicines and technologies. This model has enabled Roivant to bring to market treatments like VTAMA® (tapinarof cream, 1%) for plaque psoriasis in adults, and to advance a diverse pipeline of investigational drugs across its family of companies, including fully human monoclonal antibodies and treatments for autoimmune diseases. Roivant Sciences is headquartered in London, United Kingdom, and its shares are listed on the NASDAQ.